November 23, 2022
1 min learn
The FDA permitted Medicines360’s Liletta hormonal IUD for as much as 8 years of being pregnant prevention, based on an organization press launch.
The approval was primarily based on extra efficacy and security knowledge from a section 3 medical trial of Liletta 52 mg (levonorgestrel-releasing intrauterine system) with 1,751 girls in the US.
“Now greater than ever, sufferers want entry to secure, long-acting and reversible contraceptive choices,” Courtney A. Schreiber, MD, MPH, professor and chief of household planning at Penn Drugs in Philadelphia, mentioned within the launch. “Liletta is the one hormonal IUD permitted for 8 years with a single steady examine for the complete period, offering knowledge for sufferers and clinicians on the outcomes (excessive efficacy, low charges of hostile occasions) with long-term steady use. This approval provides well being care suppliers the power to proceed providing girls a secure and efficient possibility of being pregnant prevention for an extended time frame.”